120 related articles for article (PubMed ID: 35797940)
1. Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic.
Donoso Mantke O; Corman VM; Taddei F; McCulloch E; Niemeyer D; Grumiro L; Dirani G; Wallace PS; Drosten C; Sambri V; Niesters HGM
J Clin Virol; 2022 Sep; 154():105222. PubMed ID: 35797940
[TBL] [Abstract][Full Text] [Related]
2. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study.
Buchta C; Aberle SW; Allerberger F; Benka B; Görzer I; Griesmacher A; Hübl W; Huf W; Kapiotis S; Müller MM; Neuwirth E; Puchhammer-Stöckl E; Weseslindtner L; Camp JV
Lancet Microbe; 2023 Dec; 4(12):e1015-e1023. PubMed ID: 37979591
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment.
Chen Y; Feng L; Han Y; Zhao Z; Diao Z; Huang T; Ma Y; Feng W; Li J; Li Z; Liu C; Chang L; Li J; Zhang R
Clin Chem Lab Med; 2023 Nov; 61(12):2237-2247. PubMed ID: 37377068
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
Ast V; Costina V; Eichner R; Bode A; Aida S; Gerhards C; Thiaucourt M; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M; Haselmann V
J Clin Microbiol; 2021 Aug; 59(9):e0055921. PubMed ID: 34190575
[TBL] [Abstract][Full Text] [Related]
5. Results of German external quality assessment schemes for SARS-CoV-2 antigen detection.
Vierbaum L; Wojtalewicz N; Grunert HP; Zimmermann A; Scholz A; Goseberg S; Kaiser P; Duehring U; Drosten C; Corman V; Niemeyer D; Rabenau HF; Obermeier M; Nitsche A; Michel J; Puyskens A; Huggett JF; O'Sullivan DM; Busby E; Cowen S; Vallone PM; Cleveland MH; Falak S; Kummrow A; Schellenberg I; Zeichhardt H; Kammel M
Sci Rep; 2023 Aug; 13(1):13206. PubMed ID: 37580353
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
7. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
[TBL] [Abstract][Full Text] [Related]
9. The versatility of external quality assessment for the surveillance of laboratory and
Buchta C; Camp JV; Jovanovic J; Chiba P; Puchhammer-Stöckl E; Mayerhofer M; Plicka H; Lercher A; Popa AM; Endler L; Bergthaler A; Huf W; Benka B; Delatour V; Müller MM; Griesmacher A; Aberle SW; Görzer I
Clin Chem Lab Med; 2021 Sep; 59(10):1735-1744. PubMed ID: 34187131
[TBL] [Abstract][Full Text] [Related]
10. Correlation of SARS-CoV-2 RNA and nucleocapsid concentrations in samples used in INSTAND external quality assessment schemes.
Valiente E; Falak S; Kummrow A; Kammel M; Corman VM; Macdonald R; Zeichhardt H
BMC Res Notes; 2023 Sep; 16(1):210. PubMed ID: 37697348
[TBL] [Abstract][Full Text] [Related]
11. External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021.
Mögling R; Colavita F; Reimerink J; Melidou A; Leitmeyer K; Keramarou M; Lapa D; Francalancia M; Murk JL; Vossen A; Carletti F; Hogema B; Meijer A; Deprez L; di Caro A; Castilletti C; Reusken CB
Euro Surveill; 2022 Oct; 27(42):. PubMed ID: 36268736
[TBL] [Abstract][Full Text] [Related]
12. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
[TBL] [Abstract][Full Text] [Related]
13. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
[TBL] [Abstract][Full Text] [Related]
14. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
15. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.
Rodgers MA; Olivo A; Harris BJ; Lark C; Luo X; Berg MG; Meyer TV; Mohaimani A; Orf GS; Goldstein Y; Fox AS; Hirschhorn J; Glen WB; Nolte F; Landay A; Jennings C; Moy J; Servellita V; Chiu C; Batra R; Snell LB; Nebbia G; Douthwaite S; Tanuri A; Singh L; de Oliveira T; Ahouidi A; Mboup S; Cloherty GA
J Clin Virol; 2022 Feb; 147():105080. PubMed ID: 35086043
[TBL] [Abstract][Full Text] [Related]
16. An external quality assessment for the molecular testing of the SARS-CoV-2 virus genome in Zhejiang Province, China.
Pan J; Yan H; Li Z; Lou X; Mao H; Shi W; Yao W; Zhang Y
Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115766. PubMed ID: 36084422
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
Toptan T; Eckermann L; Pfeiffer AE; Hoehl S; Ciesek S; Drosten C; Corman VM
J Clin Virol; 2021 Feb; 135():104713. PubMed ID: 33352470
[TBL] [Abstract][Full Text] [Related]
19. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
20. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
Kittel M; Eichner R; Aida S; Bode A; Ast V; Kessler A; Neumaier M; Wölfel R; Haselmann V
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
